Cargando…
培美曲塞联合顺铂对比吉西他滨联合顺铂一线治疗晚期非鳞非小细胞肺癌的随机、对照、多中心临床研究
BACKGROUND AND OBJECTIVE: Platinum-based doublet chemotherapy is still the standard first-line treatment for non-small cell lung cancer (NSCLC). Previous studies have demonstrated that pemetrexed combined with platinum had promising efficacy and safety profile in NSCLC, especially in patients with n...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999831/ https://www.ncbi.nlm.nih.gov/pubmed/23075681 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.10.03 |
Ejemplares similares
-
培美曲塞及吉西他滨分别联合顺铂治疗初治晚期非小细胞肺癌安全性和有效性的随机对照研究
Publicado: (2012) -
培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta分析
Publicado: (2011) -
培美曲塞联合顺铂或卡铂治疗复发或转移性非小细胞肺癌63例疗效分析
Publicado: (2011) -
培美曲塞/顺铂二线治疗晚期非小细胞肺癌:一例报告及文献复习
Publicado: (2010) -
吉西他滨顺铂联合索拉非尼或安慰剂一线治疗晚期非小细胞肺癌的随机对照研究
Publicado: (2011)